nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—head and neck cancer—thyroid cancer	0.212	0.34	CtDrD
Vinblastine—germ cell cancer—thyroid cancer	0.145	0.233	CtDrD
Vinblastine—kidney cancer—thyroid cancer	0.135	0.217	CtDrD
Vinblastine—lung cancer—thyroid cancer	0.131	0.209	CtDrD
Vinblastine—ABCC6—Doxorubicin—thyroid cancer	0.0569	0.236	CbGbCtD
Vinblastine—ABCC1—Vandetanib—thyroid cancer	0.0459	0.19	CbGbCtD
Vinblastine—ABCC1—Epirubicin—thyroid cancer	0.0316	0.131	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—thyroid cancer	0.0236	0.0978	CbGbCtD
Vinblastine—ABCC2—Sorafenib—thyroid cancer	0.0205	0.0848	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—thyroid cancer	0.0168	0.0695	CbGbCtD
Vinblastine—ABCC2—Doxorubicin—thyroid cancer	0.0124	0.0514	CbGbCtD
Vinblastine—ABCB1—Sorafenib—thyroid cancer	0.00667	0.0276	CbGbCtD
Vinblastine—CYP3A4—Vandetanib—thyroid cancer	0.00663	0.0275	CbGbCtD
Vinblastine—CYP2D6—Sorafenib—thyroid cancer	0.00629	0.026	CbGbCtD
Vinblastine—ABCB1—Doxorubicin—thyroid cancer	0.00405	0.0168	CbGbCtD
Vinblastine—CYP3A4—Sorafenib—thyroid cancer	0.004	0.0166	CbGbCtD
Vinblastine—CYP2D6—Doxorubicin—thyroid cancer	0.00381	0.0158	CbGbCtD
Vinblastine—CYP3A4—Doxorubicin—thyroid cancer	0.00243	0.01	CbGbCtD
Vinblastine—Ischaemia—Sorafenib—thyroid cancer	0.00181	0.0618	CcSEcCtD
Vinblastine—TUBE1—saliva-secreting gland—thyroid cancer	0.00178	0.0435	CbGeAlD
Vinblastine—TUBG1—saliva-secreting gland—thyroid cancer	0.00159	0.0389	CbGeAlD
Vinblastine—Ileus—Vandetanib—thyroid cancer	0.00138	0.0473	CcSEcCtD
Vinblastine—TUBE1—trachea—thyroid cancer	0.00137	0.0335	CbGeAlD
Vinblastine—TUBG1—trachea—thyroid cancer	0.00123	0.03	CbGeAlD
Vinblastine—TUBA1A—neck—thyroid cancer	0.00118	0.0289	CbGeAlD
Vinblastine—JUN—neck—thyroid cancer	0.00117	0.0286	CbGeAlD
Vinblastine—TUBD1—thyroid gland—thyroid cancer	0.00116	0.0283	CbGeAlD
Vinblastine—TUBE1—thyroid gland—thyroid cancer	0.00108	0.0265	CbGeAlD
Vinblastine—Cellulitis—Vandetanib—thyroid cancer	0.00108	0.0368	CcSEcCtD
Vinblastine—TUBG1—Afatinib—Vandetanib—thyroid cancer	0.00103	0.363	CbGdCrCtD
Vinblastine—TUBB8—head—thyroid cancer	0.00103	0.0251	CbGeAlD
Vinblastine—TUBD1—head—thyroid cancer	0.00103	0.0251	CbGeAlD
Vinblastine—TUBG1—thyroid gland—thyroid cancer	0.00097	0.0238	CbGeAlD
Vinblastine—TUBE1—head—thyroid cancer	0.000962	0.0235	CbGeAlD
Vinblastine—TUBA1A—saliva-secreting gland—thyroid cancer	0.000921	0.0225	CbGeAlD
Vinblastine—JUN—saliva-secreting gland—thyroid cancer	0.000912	0.0223	CbGeAlD
Vinblastine—Neoplasm—Vandetanib—thyroid cancer	0.000884	0.0302	CcSEcCtD
Vinblastine—TUBG1—head—thyroid cancer	0.000861	0.0211	CbGeAlD
Vinblastine—NR5A1—head—thyroid cancer	0.00084	0.0206	CbGeAlD
Vinblastine—TUBB2B—saliva-secreting gland—thyroid cancer	0.000761	0.0186	CbGeAlD
Vinblastine—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.000751	0.266	CbGdCrCtD
Vinblastine—TUBB—saliva-secreting gland—thyroid cancer	0.00072	0.0176	CbGeAlD
Vinblastine—TUBD1—lymph node—thyroid cancer	0.000718	0.0176	CbGeAlD
Vinblastine—TUBB2A—saliva-secreting gland—thyroid cancer	0.000716	0.0175	CbGeAlD
Vinblastine—TUBA1A—trachea—thyroid cancer	0.00071	0.0174	CbGeAlD
Vinblastine—TUBB6—saliva-secreting gland—thyroid cancer	0.000706	0.0173	CbGeAlD
Vinblastine—JUN—trachea—thyroid cancer	0.000703	0.0172	CbGeAlD
Vinblastine—TUBB3—head—thyroid cancer	0.0007	0.0171	CbGeAlD
Vinblastine—TUBB1—head—thyroid cancer	0.000684	0.0168	CbGeAlD
Vinblastine—TUBE1—lymph node—thyroid cancer	0.000673	0.0165	CbGeAlD
Vinblastine—ABCC6—thyroid gland—thyroid cancer	0.000664	0.0163	CbGeAlD
Vinblastine—TUBB4B—saliva-secreting gland—thyroid cancer	0.000614	0.015	CbGeAlD
Vinblastine—TUBG1—lymph node—thyroid cancer	0.000603	0.0148	CbGeAlD
Vinblastine—Neoplasm—Sorafenib—thyroid cancer	0.000597	0.0204	CcSEcCtD
Vinblastine—ABCC6—head—thyroid cancer	0.000589	0.0144	CbGeAlD
Vinblastine—TUBB2B—trachea—thyroid cancer	0.000587	0.0144	CbGeAlD
Vinblastine—TUBA1A—thyroid gland—thyroid cancer	0.000562	0.0138	CbGeAlD
Vinblastine—JUN—thyroid gland—thyroid cancer	0.000556	0.0136	CbGeAlD
Vinblastine—TUBB—trachea—thyroid cancer	0.000555	0.0136	CbGeAlD
Vinblastine—TUBB2A—trachea—thyroid cancer	0.000552	0.0135	CbGeAlD
Vinblastine—Depression—Vandetanib—thyroid cancer	0.000546	0.0187	CcSEcCtD
Vinblastine—TUBB6—trachea—thyroid cancer	0.000545	0.0133	CbGeAlD
Vinblastine—Myelosuppression—Epirubicin—thyroid cancer	0.00052	0.0178	CcSEcCtD
Vinblastine—TUBA1A—head—thyroid cancer	0.000499	0.0122	CbGeAlD
Vinblastine—Haemoglobin—Vandetanib—thyroid cancer	0.000494	0.0169	CcSEcCtD
Vinblastine—JUN—head—thyroid cancer	0.000494	0.0121	CbGeAlD
Vinblastine—Haemorrhage—Vandetanib—thyroid cancer	0.000491	0.0168	CcSEcCtD
Vinblastine—Myelosuppression—Doxorubicin—thyroid cancer	0.000481	0.0165	CcSEcCtD
Vinblastine—TUBB4A—thyroid gland—thyroid cancer	0.00048	0.0118	CbGeAlD
Vinblastine—TUBB4B—trachea—thyroid cancer	0.000473	0.0116	CbGeAlD
Vinblastine—TUBB2B—thyroid gland—thyroid cancer	0.000464	0.0114	CbGeAlD
Vinblastine—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.000464	0.164	CbGdCrCtD
Vinblastine—TUBB—thyroid gland—thyroid cancer	0.000439	0.0108	CbGeAlD
Vinblastine—TUBB2A—thyroid gland—thyroid cancer	0.000437	0.0107	CbGeAlD
Vinblastine—Alopecia—Vandetanib—thyroid cancer	0.000434	0.0148	CcSEcCtD
Vinblastine—TUBB6—thyroid gland—thyroid cancer	0.000431	0.0105	CbGeAlD
Vinblastine—TUBB4A—head—thyroid cancer	0.000426	0.0104	CbGeAlD
Vinblastine—TUBB2B—head—thyroid cancer	0.000412	0.0101	CbGeAlD
Vinblastine—TUBB2A—head—thyroid cancer	0.000388	0.00949	CbGeAlD
Vinblastine—TUBB6—head—thyroid cancer	0.000382	0.00936	CbGeAlD
Vinblastine—TUBB4B—thyroid gland—thyroid cancer	0.000375	0.00917	CbGeAlD
Vinblastine—Convulsion—Vandetanib—thyroid cancer	0.000371	0.0127	CcSEcCtD
Vinblastine—Hypertension—Vandetanib—thyroid cancer	0.000369	0.0126	CcSEcCtD
Vinblastine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000364	0.0124	CcSEcCtD
Vinblastine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000362	0.0124	CcSEcCtD
Vinblastine—Myocardial infarction—Sorafenib—thyroid cancer	0.000362	0.0124	CcSEcCtD
Vinblastine—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.000354	0.125	CbGdCrCtD
Vinblastine—TUBA1A—lymph node—thyroid cancer	0.000349	0.00855	CbGeAlD
Vinblastine—JUN—lymph node—thyroid cancer	0.000346	0.00846	CbGeAlD
Vinblastine—Ileus—Epirubicin—thyroid cancer	0.000345	0.0118	CcSEcCtD
Vinblastine—Thrombocytopenia—Vandetanib—thyroid cancer	0.000342	0.0117	CcSEcCtD
Vinblastine—Nystagmus—Epirubicin—thyroid cancer	0.000341	0.0117	CcSEcCtD
Vinblastine—ABCC1—trachea—thyroid cancer	0.000337	0.00826	CbGeAlD
Vinblastine—Haemoglobin—Sorafenib—thyroid cancer	0.000333	0.0114	CcSEcCtD
Vinblastine—TUBB4B—head—thyroid cancer	0.000332	0.00813	CbGeAlD
Vinblastine—Haemorrhage—Sorafenib—thyroid cancer	0.000331	0.0113	CcSEcCtD
Vinblastine—Neuritis—Epirubicin—thyroid cancer	0.000327	0.0112	CcSEcCtD
Vinblastine—Ileus—Doxorubicin—thyroid cancer	0.000319	0.0109	CcSEcCtD
Vinblastine—Nystagmus—Doxorubicin—thyroid cancer	0.000316	0.0108	CcSEcCtD
Vinblastine—Paraesthesia—Vandetanib—thyroid cancer	0.000313	0.0107	CcSEcCtD
Vinblastine—Decreased appetite—Vandetanib—thyroid cancer	0.000303	0.0104	CcSEcCtD
Vinblastine—Neuritis—Doxorubicin—thyroid cancer	0.000302	0.0103	CcSEcCtD
Vinblastine—Pain—Vandetanib—thyroid cancer	0.000298	0.0102	CcSEcCtD
Vinblastine—Constipation—Vandetanib—thyroid cancer	0.000298	0.0102	CcSEcCtD
Vinblastine—TUBB4A—lymph node—thyroid cancer	0.000298	0.0073	CbGeAlD
Vinblastine—Alopecia—Sorafenib—thyroid cancer	0.000293	0.01	CcSEcCtD
Vinblastine—TUBB2B—lymph node—thyroid cancer	0.000288	0.00706	CbGeAlD
Vinblastine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000285	0.00976	CcSEcCtD
Vinblastine—Extravasation—Epirubicin—thyroid cancer	0.00028	0.00956	CcSEcCtD
Vinblastine—Abdominal pain—Vandetanib—thyroid cancer	0.000276	0.00943	CcSEcCtD
Vinblastine—TUBB—lymph node—thyroid cancer	0.000273	0.00668	CbGeAlD
Vinblastine—TUBB2A—lymph node—thyroid cancer	0.000271	0.00664	CbGeAlD
Vinblastine—Rectal haemorrhage—Epirubicin—thyroid cancer	0.00027	0.00923	CcSEcCtD
Vinblastine—Cellulitis—Epirubicin—thyroid cancer	0.000268	0.00917	CcSEcCtD
Vinblastine—TUBB6—lymph node—thyroid cancer	0.000268	0.00655	CbGeAlD
Vinblastine—ABCC1—thyroid gland—thyroid cancer	0.000267	0.00653	CbGeAlD
Vinblastine—Anaemia—Sorafenib—thyroid cancer	0.000267	0.00912	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—thyroid cancer	0.000259	0.00884	CcSEcCtD
Vinblastine—Leukopenia—Sorafenib—thyroid cancer	0.000258	0.00883	CcSEcCtD
Vinblastine—Bone pain—Epirubicin—thyroid cancer	0.000255	0.0087	CcSEcCtD
Vinblastine—Asthenia—Vandetanib—thyroid cancer	0.00025	0.00856	CcSEcCtD
Vinblastine—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00025	0.00854	CcSEcCtD
Vinblastine—Hypertension—Sorafenib—thyroid cancer	0.000249	0.00851	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—thyroid cancer	0.000248	0.00848	CcSEcCtD
Vinblastine—Diarrhoea—Vandetanib—thyroid cancer	0.000239	0.00816	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—thyroid cancer	0.000236	0.00805	CcSEcCtD
Vinblastine—TUBB4B—lymph node—thyroid cancer	0.000233	0.0057	CbGeAlD
Vinblastine—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.000231	0.0818	CbGdCrCtD
Vinblastine—Dizziness—Vandetanib—thyroid cancer	0.000231	0.00789	CcSEcCtD
Vinblastine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000231	0.00788	CcSEcCtD
Vinblastine—Anorexia—Sorafenib—thyroid cancer	0.000224	0.00767	CcSEcCtD
Vinblastine—Vomiting—Vandetanib—thyroid cancer	0.000222	0.00759	CcSEcCtD
Vinblastine—Neoplasm—Epirubicin—thyroid cancer	0.000221	0.00754	CcSEcCtD
Vinblastine—Headache—Vandetanib—thyroid cancer	0.000219	0.00748	CcSEcCtD
Vinblastine—Nausea—Vandetanib—thyroid cancer	0.000207	0.00709	CcSEcCtD
Vinblastine—Phlebitis—Epirubicin—thyroid cancer	0.000205	0.00703	CcSEcCtD
Vinblastine—Decreased appetite—Sorafenib—thyroid cancer	0.000205	0.007	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—thyroid cancer	0.000204	0.00698	CcSEcCtD
Vinblastine—Constipation—Sorafenib—thyroid cancer	0.000201	0.00688	CcSEcCtD
Vinblastine—Pain—Sorafenib—thyroid cancer	0.000201	0.00688	CcSEcCtD
Vinblastine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000193	0.00658	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—thyroid cancer	0.00019	0.0065	CcSEcCtD
Vinblastine—ABCC2—lymph node—thyroid cancer	0.000188	0.00461	CbGeAlD
Vinblastine—Abdominal pain—Sorafenib—thyroid cancer	0.000186	0.00636	CcSEcCtD
Vinblastine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000181	0.00618	CcSEcCtD
Vinblastine—Hypersensitivity—Sorafenib—thyroid cancer	0.000173	0.00593	CcSEcCtD
Vinblastine—Asthenia—Sorafenib—thyroid cancer	0.000169	0.00578	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000167	0.00571	CcSEcCtD
Vinblastine—ABCC1—lymph node—thyroid cancer	0.000166	0.00406	CbGeAlD
Vinblastine—Diarrhoea—Sorafenib—thyroid cancer	0.000161	0.00551	CcSEcCtD
Vinblastine—Dizziness—Sorafenib—thyroid cancer	0.000156	0.00532	CcSEcCtD
Vinblastine—Vomiting—Sorafenib—thyroid cancer	0.00015	0.00512	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—thyroid cancer	0.000149	0.0051	CcSEcCtD
Vinblastine—Headache—Sorafenib—thyroid cancer	0.000147	0.00504	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—thyroid cancer	0.000145	0.00497	CcSEcCtD
Vinblastine—Nausea—Sorafenib—thyroid cancer	0.00014	0.00478	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—thyroid cancer	0.000138	0.00471	CcSEcCtD
Vinblastine—ABCB1—trachea—thyroid cancer	0.000138	0.00337	CbGeAlD
Vinblastine—Pancytopenia—Doxorubicin—thyroid cancer	0.000134	0.0046	CcSEcCtD
Vinblastine—CYP2D6—head—thyroid cancer	0.000134	0.00329	CbGeAlD
Vinblastine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000134	0.00457	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—thyroid cancer	0.000127	0.00435	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000124	0.00423	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—thyroid cancer	0.000123	0.00421	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—thyroid cancer	0.000122	0.00419	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000122	0.00417	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—thyroid cancer	0.000122	0.00416	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000118	0.00403	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—thyroid cancer	0.000114	0.00389	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—thyroid cancer	0.000113	0.00387	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000113	0.00385	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—thyroid cancer	0.000112	0.00385	CcSEcCtD
Vinblastine—ABCB1—thyroid gland—thyroid cancer	0.000109	0.00267	CbGeAlD
Vinblastine—Alopecia—Epirubicin—thyroid cancer	0.000108	0.0037	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—thyroid cancer	0.0001	0.00342	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—thyroid cancer	9.89e-05	0.00338	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—thyroid cancer	9.85e-05	0.00337	CcSEcCtD
Vinblastine—ABCB1—head—thyroid cancer	9.66e-05	0.00237	CbGeAlD
Vinblastine—Malaise—Epirubicin—thyroid cancer	9.61e-05	0.00329	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—thyroid cancer	9.58e-05	0.00327	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—thyroid cancer	9.54e-05	0.00326	CcSEcCtD
Vinblastine—Convulsion—Epirubicin—thyroid cancer	9.24e-05	0.00316	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—thyroid cancer	9.2e-05	0.00315	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—thyroid cancer	9.15e-05	0.00313	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—thyroid cancer	9.12e-05	0.00312	CcSEcCtD
Vinblastine—Discomfort—Epirubicin—thyroid cancer	8.97e-05	0.00307	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—thyroid cancer	8.9e-05	0.00304	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—thyroid cancer	8.86e-05	0.00303	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—thyroid cancer	8.83e-05	0.00302	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—thyroid cancer	8.55e-05	0.00292	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—thyroid cancer	8.52e-05	0.00291	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—thyroid cancer	8.52e-05	0.00291	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—thyroid cancer	8.3e-05	0.00284	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—thyroid cancer	8.29e-05	0.00284	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—thyroid cancer	7.88e-05	0.00269	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—thyroid cancer	7.81e-05	0.00267	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—thyroid cancer	7.67e-05	0.00262	CcSEcCtD
Vinblastine—Decreased appetite—Epirubicin—thyroid cancer	7.56e-05	0.00259	CcSEcCtD
Vinblastine—Pain—Epirubicin—thyroid cancer	7.44e-05	0.00254	CcSEcCtD
Vinblastine—Constipation—Epirubicin—thyroid cancer	7.44e-05	0.00254	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—thyroid cancer	7.23e-05	0.00247	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—thyroid cancer	7.17e-05	0.00245	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—thyroid cancer	7.12e-05	0.00243	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—thyroid cancer	7e-05	0.00239	CcSEcCtD
Vinblastine—Pain—Doxorubicin—thyroid cancer	6.88e-05	0.00235	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—thyroid cancer	6.88e-05	0.00235	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—thyroid cancer	6.88e-05	0.00235	CcSEcCtD
Vinblastine—ABCB1—lymph node—thyroid cancer	6.77e-05	0.00166	CbGeAlD
Vinblastine—Feeling abnormal—Doxorubicin—thyroid cancer	6.63e-05	0.00227	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—thyroid cancer	6.58e-05	0.00225	CcSEcCtD
Vinblastine—Hypersensitivity—Epirubicin—thyroid cancer	6.41e-05	0.00219	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—thyroid cancer	6.36e-05	0.00218	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—thyroid cancer	6.24e-05	0.00213	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—thyroid cancer	5.95e-05	0.00204	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—thyroid cancer	5.93e-05	0.00203	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—thyroid cancer	5.78e-05	0.00197	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—thyroid cancer	5.75e-05	0.00197	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—thyroid cancer	5.53e-05	0.00189	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—thyroid cancer	5.51e-05	0.00188	CcSEcCtD
Vinblastine—Headache—Epirubicin—thyroid cancer	5.45e-05	0.00186	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—thyroid cancer	5.32e-05	0.00182	CcSEcCtD
Vinblastine—Nausea—Epirubicin—thyroid cancer	5.17e-05	0.00177	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—thyroid cancer	5.12e-05	0.00175	CcSEcCtD
Vinblastine—Headache—Doxorubicin—thyroid cancer	5.04e-05	0.00172	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—thyroid cancer	4.78e-05	0.00163	CcSEcCtD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TP53—thyroid cancer	2.87e-05	0.000463	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CALCB—thyroid cancer	2.87e-05	0.000462	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	2.83e-05	0.000456	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.83e-05	0.000456	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CHST14—thyroid cancer	2.83e-05	0.000456	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	2.81e-05	0.000452	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	2.8e-05	0.000451	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.8e-05	0.000451	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—KRAS—thyroid cancer	2.8e-05	0.000451	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.79e-05	0.000449	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—HRAS—thyroid cancer	2.77e-05	0.000447	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.76e-05	0.000444	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.76e-05	0.000444	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—HRAS—thyroid cancer	2.73e-05	0.000439	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TRIM33—thyroid cancer	2.72e-05	0.000438	CbGpPWpGaD
Vinblastine—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—thyroid cancer	2.69e-05	0.000433	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—PTEN—thyroid cancer	2.68e-05	0.000432	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.67e-05	0.00043	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	2.66e-05	0.000429	CbGpPWpGaD
Vinblastine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.66e-05	0.000429	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	2.66e-05	0.000428	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	2.64e-05	0.000425	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	2.62e-05	0.000423	CbGpPWpGaD
Vinblastine—JUN—Wnt Signaling Pathway and Pluripotency—TP53—thyroid cancer	2.62e-05	0.000423	CbGpPWpGaD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—HRAS—thyroid cancer	2.61e-05	0.000421	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—AKT1—thyroid cancer	2.59e-05	0.000417	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—TP53—thyroid cancer	2.56e-05	0.000413	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TERT—thyroid cancer	2.55e-05	0.000411	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—KRAS—thyroid cancer	2.55e-05	0.000411	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—KRAS—thyroid cancer	2.51e-05	0.000404	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.5e-05	0.000403	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TP53—thyroid cancer	2.49e-05	0.000401	CbGpPWpGaD
Vinblastine—JUN—Signaling by NOTCH—TP53—thyroid cancer	2.49e-05	0.000401	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—PPARG—thyroid cancer	2.48e-05	0.000399	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—PTEN—thyroid cancer	2.47e-05	0.000398	CbGpPWpGaD
Vinblastine—JUN—Androgen receptor signaling pathway—AKT1—thyroid cancer	2.47e-05	0.000398	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CHST14—thyroid cancer	2.47e-05	0.000397	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.47e-05	0.000397	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—HRAS—thyroid cancer	2.45e-05	0.000395	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—HRAS—thyroid cancer	2.45e-05	0.000395	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—AKT1—thyroid cancer	2.45e-05	0.000394	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	2.44e-05	0.000393	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.44e-05	0.000393	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—CCND1—thyroid cancer	2.42e-05	0.00039	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.41e-05	0.000388	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—AKT1—thyroid cancer	2.41e-05	0.000388	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.4e-05	0.000387	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CDK1—thyroid cancer	2.39e-05	0.000385	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—HRAS—thyroid cancer	2.38e-05	0.000383	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—PTEN—thyroid cancer	2.34e-05	0.000376	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TERT—thyroid cancer	2.33e-05	0.000376	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.33e-05	0.000375	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—TP53—thyroid cancer	2.32e-05	0.000374	CbGpPWpGaD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—AKT1—thyroid cancer	2.31e-05	0.000372	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—NRAS—thyroid cancer	2.3e-05	0.000371	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IFNA2—thyroid cancer	2.3e-05	0.00037	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	2.29e-05	0.000369	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HPGD—thyroid cancer	2.28e-05	0.000368	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CCND1—thyroid cancer	2.23e-05	0.00036	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—PTEN—thyroid cancer	2.23e-05	0.00036	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	2.22e-05	0.000357	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—NRAS—thyroid cancer	2.21e-05	0.000355	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—HRAS—thyroid cancer	2.17e-05	0.000349	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—AKT1—thyroid cancer	2.16e-05	0.000349	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	2.16e-05	0.000348	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	2.16e-05	0.000347	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TCF7L1—thyroid cancer	2.14e-05	0.000345	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TP53—thyroid cancer	2.13e-05	0.000344	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—HRAS—thyroid cancer	2.13e-05	0.000343	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.12e-05	0.000342	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	2.11e-05	0.00034	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—AKT1—thyroid cancer	2.1e-05	0.000338	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.1e-05	0.000338	CbGpPWpGaD
Vinblastine—JUN—Immune System—TPR—thyroid cancer	2.05e-05	0.000331	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	2.04e-05	0.000328	CbGpPWpGaD
Vinblastine—JUN—Immune System—LGALS3—thyroid cancer	2.04e-05	0.000328	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP53—thyroid cancer	2.04e-05	0.000328	CbGpPWpGaD
Vinblastine—JUN—Immune System—PRKAR1A—thyroid cancer	2.02e-05	0.000326	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.99e-05	0.000321	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HPGD—thyroid cancer	1.99e-05	0.00032	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—KRAS—thyroid cancer	1.98e-05	0.000319	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NRG1—thyroid cancer	1.92e-05	0.000309	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—TP53—thyroid cancer	1.92e-05	0.000309	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—AKT1—thyroid cancer	1.91e-05	0.000308	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—HRAS—thyroid cancer	1.9e-05	0.000307	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	1.9e-05	0.000306	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.85e-05	0.000298	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.83e-05	0.000294	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TCF7L1—thyroid cancer	1.82e-05	0.000292	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—AKT1—thyroid cancer	1.8e-05	0.00029	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.79e-05	0.000288	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.78e-05	0.000287	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CCND1—thyroid cancer	1.78e-05	0.000287	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.76e-05	0.000284	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TP53—thyroid cancer	1.76e-05	0.000284	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—BRAF—thyroid cancer	1.75e-05	0.000283	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—HRAS—thyroid cancer	1.75e-05	0.000282	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TPR—thyroid cancer	1.75e-05	0.000281	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	1.73e-05	0.000279	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	1.73e-05	0.000279	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PRKAR1A—thyroid cancer	1.72e-05	0.000277	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MINPP1—thyroid cancer	1.69e-05	0.000272	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—AKT1—thyroid cancer	1.68e-05	0.000271	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.65e-05	0.000266	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—TP53—thyroid cancer	1.62e-05	0.000261	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.62e-05	0.000261	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	1.61e-05	0.00026	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MINPP1—thyroid cancer	1.59e-05	0.000256	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.59e-05	0.000256	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TPR—thyroid cancer	1.57e-05	0.000252	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.56e-05	0.000251	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—AKT1—thyroid cancer	1.55e-05	0.000249	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PRKAR1A—thyroid cancer	1.54e-05	0.000248	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.53e-05	0.000247	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	1.53e-05	0.000246	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—HRAS—thyroid cancer	1.53e-05	0.000246	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TP53—thyroid cancer	1.52e-05	0.000246	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.51e-05	0.000243	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—AKT1—thyroid cancer	1.49e-05	0.000239	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CCND1—thyroid cancer	1.48e-05	0.000238	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MEN1—thyroid cancer	1.47e-05	0.000237	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TP53—thyroid cancer	1.47e-05	0.000237	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.43e-05	0.000231	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	1.43e-05	0.00023	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.41e-05	0.000228	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDK1—thyroid cancer	1.39e-05	0.000224	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.35e-05	0.000218	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CCND1—thyroid cancer	1.35e-05	0.000217	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CHST14—thyroid cancer	1.35e-05	0.000217	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—AKT1—thyroid cancer	1.35e-05	0.000217	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.34e-05	0.000216	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNA2—thyroid cancer	1.34e-05	0.000216	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.33e-05	0.000215	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.33e-05	0.000215	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSHR—thyroid cancer	1.33e-05	0.000214	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TPR—thyroid cancer	1.31e-05	0.000211	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.31e-05	0.000211	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.000211	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PRKAR1A—thyroid cancer	1.31e-05	0.000211	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PRKAR1A—thyroid cancer	1.29e-05	0.000208	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CHST14—thyroid cancer	1.27e-05	0.000205	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MEN1—thyroid cancer	1.25e-05	0.000201	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.23e-05	0.000199	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—thyroid cancer	1.23e-05	0.000197	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000197	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—thyroid cancer	1.17e-05	0.000189	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CALCA—thyroid cancer	1.17e-05	0.000189	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.17e-05	0.000188	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TPR—thyroid cancer	1.14e-05	0.000184	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTCH1—thyroid cancer	1.13e-05	0.000182	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	1.12e-05	0.000181	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRG1—thyroid cancer	1.12e-05	0.00018	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000177	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HPGD—thyroid cancer	1.09e-05	0.000175	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.07e-05	0.000172	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDK1—thyroid cancer	1.06e-05	0.000171	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	1.05e-05	0.00017	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.05e-05	0.000169	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.04e-05	0.000167	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SST—thyroid cancer	1.03e-05	0.000166	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HPGD—thyroid cancer	1.02e-05	0.000165	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.98e-06	0.000161	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CALCA—thyroid cancer	9.94e-06	0.00016	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SLC5A5—thyroid cancer	9.82e-06	0.000158	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—AKT1—thyroid cancer	9.79e-06	0.000158	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—thyroid cancer	9.72e-06	0.000157	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PTEN—thyroid cancer	9.61e-06	0.000155	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.47e-06	0.000153	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.2e-06	0.000148	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.14e-06	0.000147	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDK1—thyroid cancer	9e-06	0.000145	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—thyroid cancer	8.89e-06	0.000143	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	8.83e-06	0.000142	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NRAS—thyroid cancer	8.57e-06	0.000138	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	8.55e-06	0.000138	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRG1—thyroid cancer	8.52e-06	0.000137	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.38e-06	0.000135	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CHST14—thyroid cancer	8.31e-06	0.000134	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—RXRA—thyroid cancer	8.25e-06	0.000133	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—thyroid cancer	8.07e-06	0.00013	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.03e-06	0.000129	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—thyroid cancer	7.65e-06	0.000123	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—thyroid cancer	7.38e-06	0.000119	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HIF1A—thyroid cancer	7.32e-06	0.000118	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRG1—thyroid cancer	7.23e-06	0.000116	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—RXRA—thyroid cancer	7.19e-06	0.000116	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.02e-06	0.000113	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—thyroid cancer	6.94e-06	0.000112	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPGD—thyroid cancer	6.7e-06	0.000108	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—thyroid cancer	6.49e-06	0.000104	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—thyroid cancer	6.27e-06	0.000101	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TPR—thyroid cancer	6.24e-06	0.000101	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.24e-06	0.000101	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HIF1A—thyroid cancer	6.2e-06	9.99e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	6.14e-06	9.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—thyroid cancer	6.06e-06	9.76e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TPR—thyroid cancer	5.88e-06	9.47e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	5.79e-06	9.32e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—thyroid cancer	5.6e-06	9.02e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—thyroid cancer	5.54e-06	8.92e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—thyroid cancer	5.46e-06	8.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.27e-06	8.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—thyroid cancer	5.21e-06	8.39e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—thyroid cancer	5.14e-06	8.28e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRAS—thyroid cancer	4.99e-06	8.04e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—thyroid cancer	4.89e-06	7.88e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—thyroid cancer	4.76e-06	7.66e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A5—thyroid cancer	4.67e-06	7.53e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—thyroid cancer	4.54e-06	7.31e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	4.4e-06	7.09e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—thyroid cancer	4.3e-06	6.92e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—thyroid cancer	4.27e-06	6.87e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—thyroid cancer	4.1e-06	6.6e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—RXRA—thyroid cancer	3.93e-06	6.32e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TPR—thyroid cancer	3.85e-06	6.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRAS—thyroid cancer	3.81e-06	6.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.78e-06	6.09e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—thyroid cancer	3.75e-06	6.04e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—RXRA—thyroid cancer	3.7e-06	5.96e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—thyroid cancer	3.65e-06	5.88e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—thyroid cancer	3.62e-06	5.83e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—thyroid cancer	3.57e-06	5.76e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—thyroid cancer	3.57e-06	5.75e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—thyroid cancer	3.28e-06	5.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRAS—thyroid cancer	3.23e-06	5.2e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—thyroid cancer	3.23e-06	5.2e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—thyroid cancer	3.11e-06	5.01e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.88e-06	4.64e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—thyroid cancer	2.79e-06	4.49e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—thyroid cancer	2.78e-06	4.48e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—thyroid cancer	2.74e-06	4.42e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—thyroid cancer	2.48e-06	3.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—thyroid cancer	2.47e-06	3.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—thyroid cancer	2.46e-06	3.96e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—RXRA—thyroid cancer	2.42e-06	3.9e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—thyroid cancer	2.36e-06	3.8e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—thyroid cancer	2.34e-06	3.76e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—thyroid cancer	2.09e-06	3.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—thyroid cancer	2.06e-06	3.32e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.95e-06	3.14e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.84e-06	2.96e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—thyroid cancer	1.79e-06	2.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—thyroid cancer	1.7e-06	2.74e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—thyroid cancer	1.6e-06	2.58e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.53e-06	2.46e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.2e-06	1.93e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.05e-06	1.69e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—thyroid cancer	9.8e-07	1.58e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—thyroid cancer	9.23e-07	1.49e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—thyroid cancer	6.04e-07	9.72e-06	CbGpPWpGaD
